6 Bargain Biotech Stocks
Michael Shulman, July 10, 2009
Free Trading Guides
-
The Next Housing Crisi is About to Start -- Are You Ready to Profit?
-
Last year, as the market sank, one group actually went up—large-cap, cashflow positive genomics and biotech companies. This year, interest has shifted to the little guys—the speculative biotech stocks that could be 10- or 20-baggers with one breakthrough.
More and more, biotech stocks appear to be trading independent of anything but a market crash. Just look at Compugen (CGEN), which went from 40 cents to $2 this year, or Curis (CRIS), which jumped from 80 cents to $1.60.
Three years ago, many biotech stocks would be trading five to 20 times higher than they are today based on the potential of their science—and they'll have their day in the sun again. So I've put together a list of six biotech companies that you should take a look at now.
More By This Expert
What are the five rules for constructing great short-side positions? Read on to find out.
10 Reasons to Use ETFs When Trading Options
How do investors and traders cope with a market that has fallen more than 40% in just one year and survive until greener pastures return?
The Bad News Victims of 2008 are the
New Victors of 2009
There were a lot of losing trades last year, but there were also winners for those willing to bet against conventional wisdom -- and this will be the case in 2009, too.
The 10 Dumbest Analyst Calls of 2008
This collection of calls has been easier to write than See Spot Run. My only difficulty has been restraining myself in order to not be sued, punched out or have my tires slashed.
Don't Stop 'Banking' on a Bailout
The Titanic is only just approaching the iceberg. And there aren't enough lifeboats handy for everyone who's going to need one.
